We are live on
!
Find out more
FP
Foundry Partners Portfolio holdings
AUM
$1.89B
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.27%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$2.42B
AUM Growth
-$119M
(-4.7%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
11.89%
Holding
424
New
35
Increased
125
Reduced
216
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$22.3M |
| 2 |
AES
AES
|
+$14M |
| 3 |
SNV
Synovus
SNV
|
+$13.3M |
| 4 |
Delta Air Lines
DAL
|
+$12.8M |
| 5 |
Albemarle
ALB
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$21.4M |
| 2 |
Cisco
CSCO
|
+$18.9M |
| 3 |
Johnson & Johnson
JNJ
|
+$16.4M |
| 4 |
HP
HPQ
|
+$13.9M |
| 5 |
GSK
GSK
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.35% |
| 2 | Industrials | 15.2% |
| 3 | Technology | 9.4% |
| 4 | Healthcare | 8.25% |
| 5 | Consumer Discretionary | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Nelnet
NNI
$4.71B
| $4.69M | 0.19% |
73,777
+4,538
| +7% | +$291K |
|
177
AngioDynamics
ANGO
$553M
| $4.52M | 0.19% |
245,204
-12,988
| -5% | -$254K |
|
178
Matrix Service
MTRX
$356M
| $4.46M | 0.18% |
259,975
-18,670
| -7% | -$352K |
|
179
CoreCivic
CXW
$3.12B
| $4.43M | 0.18% |
256,651
+27,028
| +12% | +$475K |
|
|
IPHS
180
DELISTED
Innophos Holdings, Inc.
IPHS
| $4.42M | 0.18% |
+136,070
| New | +$3.92M |
|
181
The GEO Group
GEO
$4.1B
| $4.37M | 0.18% |
252,178
+26,721
| +12% | +$479K |
|
182
Park-Ohio Holdings
PKOH
$537M
| $4.37M | 0.18% |
146,180
+15,499
| +12% | +$462K |
|
183
Spok Holdings
SPOK
$220M
| $4.35M | 0.18% |
364,260
-14,780
| -4% | -$191K |
|
184
Ezcorp Inc
EZPW
$1.84B
| $4.32M | 0.18% |
669,400
+59,700
| +10% | +$511K |
|
|
EGRX
185
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.31M | 0.18% |
76,160
+2,775
| +4% | +$156K |
|
|
NXGN
186
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.23M | 0.17% |
269,672
+28,579
| +12% | +$475K |
|
187
Citi Trends
CTRN
$519M
| $4.22M | 0.17% |
230,860
+10,200
| +5% | +$166K |
|
188
Rush Enterprises Class A
RUSHA
$5.91B
| $4.21M | 0.17% |
245,599
+25,990
| +12% | +$432K |
|
189
Century Casinos
CNTY
$33.5M
| $4.17M | 0.17% |
539,175
-31,150
| -5% | -$271K |
|
190
ArcBest
ARCB
$3.48B
| $4.12M | 0.17% |
135,432
+7,713
| +6% | +$222K |
|
|
MAGN
191
Magnera Corp
MAGN
$464M
| $4.11M | 0.17% |
20,561
-1,079
| -5% | -$216K |
|
|
GHL
192
DELISTED
Greenhill & Co., Inc.
GHL
| $4.1M | 0.17% |
312,445
+21,200
| +7% | +$303K |
|
|
HTB
193
HomeTrust Bancshares
HTB
$811M
| $4.07M | 0.17% |
156,225
-8,850
| -5% | -$226K |
|
194
Banc of California
BANC
$3.25B
| $4.05M | 0.17% |
286,770
+114,775
| +67% | +$1.66M |
|
195
Silicom
SILC
$244M
| $4.01M | 0.17% |
127,053
-7,200
| -5% | -$225K |
|
|
RTEC
196
DELISTED
Rudolph Technologies Inc
RTEC
| $3.98M | 0.16% |
150,785
+8,715
| +6% | +$221K |
|
197
Ameris Bancorp
ABCB
$5.96B
| $3.95M | 0.16% |
98,265
+5,847
| +6% | +$220K |
|
|
SWIR
198
DELISTED
Sierra Wireless
SWIR
| $3.81M | 0.16% |
355,955
+17,995
| +5% | +$205K |
|
|
FNHC
199
DELISTED
FedNat Holding Company Common Stock
FNHC
| $3.8M | 0.16% |
271,740
-13,575
| -5% | -$177K |
|
200
Movado Group
MOV
$797M
| $3.76M | 0.16% |
151,187
+13,535
| +10% | +$336K |
|
Similar funds
ST
UH
PAME
TW
AP
MBA
SSB
CC
Foundry Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Foundry Partners held 424 positions worth $2.42B, down 4.7% from $2.54B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Foundry Partners withdrew a net $116M in Q3 2019, closing 37 positions and reducing 216 holdings. Its most notable exit was Allergan plc, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.
Against the trend, Foundry Partners opened a new position in Altria Group worth $19.8M.
- Foundry Partners's largest Q3 2019 buy was Altria Group: 484,800 shares worth $19.8M.
- Foundry Partners added most to Gilead Sciences in Q3 2019, an estimated $11.6M increase.
- Foundry Partners's biggest Q3 2019 reduction was Cisco, cutting an estimated $18.9M.
- Foundry Partners fully exited Allergan plc in Q3 2019, selling an estimated $21.4M.
- Foundry Partners's ten largest holdings make up 12% of its $2.42B portfolio in Q3 2019.
- Foundry Partners opened 35 new positions and closed 37 in Q3 2019.
- Foundry Partners's portfolio value fell 4.7% quarter-over-quarter to $2.42B.
Based on Foundry Partners's 13F filing for Q3 2019, filed 23 Oct 2019.